Paul Capriotti
Psychiatry · Lisle, ILNPI 1609859271
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.3% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations.
Across 123 payments — averaging $21.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$483
- Neurocrine Biosciences, Inc.$389
- Vanda Pharmaceuticals Inc.$266
- Otsuka America Pharmaceutical, Inc.$246
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$227
- Otsuka Pharmaceutical Development & Commercialization, Inc.$175
- plus $832 from 14 others
What the payments were for
- Consulting fees$1757%
- Food & beverage$2,44293%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY MYCITE$175
How this compares
$2,617 in reported general payments places this provider in the 85th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Wellbutrin XlBupropion Hcl | 13 | $29,195 |
| Effexor XrVenlafaxine Hcl | 14 | $6,603 |
| Lisdexamfetamine Dimesylate | 24 | $5,668 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 37 | $4,773 |
| Methylphenidate Er (La)Methylphenidate Hcl | 15 | $2,536 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 87 | $2,482 |
| Olanzapine | 40 | $1,946 |
| Duloxetine Hcl | 81 | $1,677 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 18 | $1,577 |
| Clozapine | 13 | $1,382 |
| KlonopinClonazepam | 12 | $1,320 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 38 | $1,221 |
| Bupropion XlBupropion Hcl | 88 | $1,195 |
| Gabapentin | 50 | $1,114 |
| Alprazolam | 114 | $816 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Lisle
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Mark ShukhmanSkokie$250K
- Abid NazeerOak Brook$228K
- Nitin ThaparOrland Park$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.